The complement system plays an important role in providing resistance to infections and in the pathogenesis of tissue injury. Yet an inappropriate activation of complement can result in a variety of disorders. The present invention provides C1s catalytic site-directed moieties, C1s exosite binding moieties, and bivalent polypeptide inhibitors comprising such moieties, which can be used to treat conditions characterized by inappropriate complement activation.

 
Web www.patentalert.com

< Anti-PRO788 antibodies

< Elongase genes and uses thereof

> Methods of purifying authentic IGF from yeast hosts

> Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods

~ 00275